Trial intelligence / Profile preview

Shensong Yangxin capsule in heart failure with ventricular premature beats

NCT01612260Phase 4Unknown

Start
Sep 2012
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of shensong yangxin capsule in heart failure (HF), ventricular premature complex (PVC). Status: unknown.

02

Drugs

shensong yangxin capsule
03

Conditions

heart failure (HF)ventricular premature complex (PVC)

Beyond the preview

Go deeper on NCT01612260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01612260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call